Masami Ishibashi Selected Research

Body Weight (Weight, Body)

3/2009

Structure of new monoterpene glycoside from Sibiraea angustata RCHD. and its anti-obestic effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masami Ishibashi Research Topics

Disease

19	Neoplasms (Cancer) 09/2019 - 01/2006
15	Adenocarcinoma 03/2022 - 08/2009
4	Colonic Neoplasms (Colon Cancer) 09/2015 - 04/2009
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 11/2008
2	Carcinoma (Carcinomatosis) 01/2017 - 12/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2011 - 11/2008
1	Hypoxia (Hypoxemia) 01/2021
1	Infections 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 12/2016
1	Carcinogenesis 04/2009
1	Body Weight (Weight, Body) 03/2009
1	Weight Loss (Weight Reduction) 03/2009
1	Leukemia 09/2007
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2006
1	Leukemia P388 06/2003

Drug/Important Bio-Agent (IBA)

13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 09/2007
11	LigandsIBA 03/2022 - 09/2007
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2008
4	TNF-Related Apoptosis-Inducing LigandIBA 07/2016 - 09/2007
4	CateninsIBA 09/2015 - 12/2013
3	Messenger RNA (mRNA)IBA 01/2019 - 08/2009
3	Biological ProductsIBA 12/2016 - 10/2010
2	FlavonoidsIBA 01/2017 - 01/2011
2	fuligocandin BIBA 12/2016 - 09/2007
2	Antineoplastic Agents (Antineoplastics)IBA 07/2016 - 01/2016
2	Death Domain ReceptorsIBA 09/2009 - 01/2006
1	corilaginIBA 03/2022
1	EnzymesIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	nocobactin NA-bIBA 01/2021
1	nocobactin NA-aIBA 01/2021
1	Cardiac GlycosidesIBA 09/2020
1	elaiophylinIBA 01/2019
1	LignansIBA 06/2018
1	quinolineIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	Valosin Containing ProteinIBA 12/2016
1	Apoptosis Regulatory ProteinsIBA 01/2016
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 09/2015
1	coronardineIBA 09/2015
1	Proteasome InhibitorsIBA 09/2015
1	scopadulciolIBA 04/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2014
1	calotropinIBA 04/2014
1	CardenolidesIBA 04/2014
1	Casein Kinases (Casein Kinase)IBA 04/2014
1	GlycosidesIBA 01/2011
1	cryptolepineIBA 01/2011
1	ProstaglandinsIBA 10/2010
1	Free RadicalsIBA 10/2010
1	1,1-diphenyl-2-picrylhydrazylIBA 10/2010
1	Caspase 3 (Caspase-3)IBA 08/2010
1	Patched-1 ReceptorIBA 05/2010
1	1,3,5,8- tetrahydroxy- 2,4- bis(3- methyl- 2- butenyl)xanthoneIBA 03/2010
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 08/2009
1	beta CateninIBA 04/2009
1	1- O- beta- D- glucopyranosyl- geraniol- 5,10- olideIBA 03/2009
1	Triglycerides (Triacylglycerol)IBA 03/2009
1	SugarsIBA 03/2009
1	TriterpenesIBA 11/2008
1	zerumboneIBA 12/2007
1	cycloanthranilylprolineIBA 09/2007
1	PPAR gammaIBA 09/2007
1	9-deoxy-delta-9-prostaglandin D2IBA 09/2007
1	wrightiamine AIBA 06/2003
1	Vincristine (Oncovin)FDA LinkGeneric 06/2003

Therapy/Procedure

8	Therapeutics 09/2019 - 01/2006
1	Oral Administration 03/2009